Albert Lo
Impact in
- Oncology top 1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
- Cancer Cells and Metastasis
- Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 10
- Peptidase Inhibition and Analysis 5
- CAR-T cell therapy research 5
-
- Glycosylation and Glycoproteins Research 3
- Ubiquitin and proteasome pathways 2
- Co-authors
- Ellen Puré (8 shared papers)Steven Μ. Albelda (5 shared papers)Carl H. June (4 shared papers)Kheng Newick (5 shared papers)Edmund K. Moon (5 shared papers)Liang‐Chuan S. Wang (3 shared papers)Han‐Chung Wu (4 shared papers)Amy C. Durham (2 shared papers)
- Journals
- Cancer Immunology Research (4 papers)Cancer Research (3 papers)Human Pathology (1 paper)Clinical Cancer Research (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United StatesTaiwanChina
In The Last Decade
Albert Lo
18 papers receiving 2.8k citations
Albert Lo's Hit Papers
Peers
Comparison fields: 5 of 85
- Oncology 2.0k
- Immunology 746
- Cancer Research 231
- Genetics 453
- Molecular Biology 982
Countries citing papers authored by Albert Lo
This map shows the geographic impact of Albert Lo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Lo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Lo more than expected).
Fields of papers citing papers by Albert Lo
This network shows the impact of papers produced by Albert Lo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Lo. The network helps show where Albert Lo may publish in the future.
Co-authors
The 25 scholars most cited alongside Albert Lo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity Hit paper breakdown → | 2013 | 535 |
| 2 | A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors Hit paper breakdown → | 2016 | 428 |
| 3 | Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells Hit paper breakdown → | 2015 | 411 |
| 4 | 2019 | 227 | |
| 5 | 2016 | 163 | |
| 6 | 2008 | 155 | |
| 7 | 2017 | 145 | |
| 8 | 2017 | 116 | |
| 9 | 2015 | 98 | |
| 10 | 2015 | 92 | |
| 11 | 2016 | 90 | |
| 12 | 2015 | 84 | |
| 13 | 2013 | 84 | |
| 14 | 2009 | 83 | |
| 15 | 2013 | 73 | |
| 16 | 2013 | 24 | |
| 17 | 2013 | 23 | |
| 18 | Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery | 2008 | 4 |
About Albert Lo
Albert Lo is a scholar working on Oncology, Molecular Biology, Immunology, Radiology, Nuclear Medicine and Imaging and Biomaterials, having authored 18 papers that have together received 2.8k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (5 papers), Immune Cell Function and Interaction (5 papers), CAR-T cell therapy research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers), Ubiquitin and proteasome pathways (2 papers), T-cell and B-cell Immunology (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). The work is most often cited by research in Oncology (2.0k citations), Immunology (746 citations), Cancer Research (231 citations), Genetics (453 citations) and Molecular Biology (982 citations). Albert Lo has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Ellen Puré, Steven Μ. Albelda, Carl H. June, Kheng Newick, Edmund K. Moon, Liang‐Chuan S. Wang, Han‐Chung Wu, Amy C. Durham, John Scholler and Jing Sun. Their work appears in journals such as Cancer Immunology Research, Cancer Research, Human Pathology, Clinical Cancer Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.